Pathak Anuj Kumar, Kumar Manish, Dokania Shambhu, Mohan Lalit, Dikshit Harihar
Senior Resident, Department of Pharmacology, IGIMS , Sheikhpura, Patna, Bihar, India .
Assistant Professor, Department of Pharmacology, IGIMS , Sheikhpura, Patna, Bihar, India .
J Clin Diagn Res. 2016 Aug;10(8):FC01-4. doi: 10.7860/JCDR/2016/18826.8284. Epub 2016 Aug 1.
Pharmacovigilance (PV) is related to detection, assessment, understanding and prevention of Adverse Drug Reactions (ADRs) which are incurred when drug is made available in the market and used in different physiological conditions. In many countries, ADRs ranks among the top ten leading cause of morbidity and mortality. There is a lack of formal culture for monitoring and reporting of ADRs in India, with ADR reporting rate being only 1% as compared to 5% in world. This type of academic detailing activity helps to create awareness of ADR reporting in the institutions.
This study was planned to evaluate and analyse the incidence and patterns of ADRs in various inpatient and outpatient departments of hospital.
This was an observational, retrospective and record based study conducted by analysing the spontaneous ADR forms, collected over a period of 12 months (September 2014 to August 2015) at Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.
During the period of one year, 292 ADR forms were collected from 4,34,965 patients attending OPD and inpatients of the hospital. Incidence of ADR was 0.67 per thousand patients and average of around 24 ADR collected per month. Male:Female ratio was 1.30. Adolescent (16-30 yr) was the most common age group affected. Department of Skin and VD reported the maximum number of ADRs (33.22%), followed by the Departments of Oncology (18.84%). Antibiotics were the most common drug implicated followed by anticancer drugs.
ADR reporting is an ongoing and continuous process. Studies from the institute helps to identify and rectify the problems related to ADR reporting. Pitfalls can be addressed by creating awareness among physicians and the patients to achieve finally the goal of Pharmacovigilant India.
药物警戒(PV)与药品上市并用于不同生理状况时所发生的药品不良反应(ADR)的发现、评估、理解及预防相关。在许多国家,药品不良反应位列发病和死亡的十大主要原因之中。印度缺乏监测和报告药品不良反应的正规文化,药品不良反应报告率仅为1%,而全球报告率为5%。此类学术详细阐述活动有助于在各机构中提高对药品不良反应报告的认识。
本研究旨在评估和分析医院各住院和门诊科室药品不良反应的发生率及模式。
这是一项基于观察、回顾和记录的研究,通过分析2014年9月至2015年8月期间在印度比哈尔邦巴特那英迪拉·甘地医学科学研究所收集的12个月内的自发药品不良反应表格进行。
在一年期间,从该医院门诊和住院的434965名患者中收集到292份药品不良反应表格。药品不良反应发生率为每千名患者0.67例,平均每月收集约24例药品不良反应。男女比例为1.30。青少年(16 - 30岁)是受影响最常见的年龄组。皮肤与性病科报告的药品不良反应数量最多(33.22%),其次是肿瘤科(18.84%)。抗生素是最常涉及的药物,其次是抗癌药物。
药品不良反应报告是一个持续不断的过程。该研究所的研究有助于识别和纠正与药品不良反应报告相关的问题。通过提高医生和患者的认识可以解决这些问题,最终实现印度药物警戒的目标。